Concepedia

Publication | Open Access

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

DOIFull Paper Access

132

Citations

26

References

2019

Year

Arun Rajan, Christopher R. Heery, Anish Thomas, Andrew L. Mammen, Susan Perry, Geraldine O’Sullivan Coyne, Udayan Guha, Arlene Berman, Éva Szabó, Ravi A. Madan,
Journal for ImmunoTherapy of Cancer

Abstract

ClinicalTrials.gov - NCT01772004 . Date of registration - January 21, 2013.

References

YearCitations

Page 1